
Reset all filters
01 2Actavis Inc
02 3Bausch & Lomb Incorporated
Reset all filters
01 2TABLET, EXTENDED RELEASE; ORAL
02 3TABLET, EXTENDED RELEASE;ORAL
Reset all filters
01 3RX
02 2Blank
Reset all filters
01 3APLENZIN
02 2BUPROPION HYDROBROMIDE
Reset all filters
01 5USA
Regulatory Info :
Registration Country : USA
Brand Name : BUPROPION HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Dosage Strength : 174MG
Packaging :
Approval Date :
Application Number : 200835
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BUPROPION HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Dosage Strength : 522MG
Packaging :
Approval Date :
Application Number : 200835
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APLENZIN
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 174MG
Packaging :
Approval Date : 2008-04-23
Application Number : 22108
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APLENZIN
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 348MG
Packaging :
Approval Date : 2008-04-23
Application Number : 22108
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APLENZIN
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 522MG
Packaging :
Approval Date : 2008-04-23
Application Number : 22108
Regulatory Info : RX
Registration Country : USA